Abstract:Objective: To investigate the expression of MEG3 in lung cancer and the role of MEG3 in the invasion and migration of lung cancer cells and its mechanism. Methods: The expression of MEG3 in lung cancer and adjacent lung cancer cells was detected by qPCR. Transwell invasion assay was used to detect the invasion ability of lung cancer cells after silencing MEG3. The migration ability of lung cancer cells after silencing MEG3 was detected by scratch test. The expression of miR-219a was detected by flow cytometry. The expression of miR-219a in lung cancer and adjacent tissues and different lung cancer cells was detected by qPCR. Transwell invasion assay was used to detect the effect of miR-219a on the invasion of lung cancer cells after silencing MEG3. The effect of miR-219a on the tumor size and volume of lung cancer was detected by subcutaneous tumorigenesis of MEG3 in nude mice. The effect of miR-219a on the tumor size and volume of lung cancer cells was detected by scintigraphy. Western blotting was used to detect the expression of Notch pathway protein after silencing MEG3. The morphological changes of microcapsule microtubules after silencing MEG3 were detected by phalloidin staining. Results: The expression of MEG3 was significantly increased in lung cancer tissues compared with adjacent tissues; The expression of MEG3 was the highest in lung cancer cell A549; MEG3 could specifically bind to 3’UTR of miR-219a; The expression of miR-219a was significantly decreased in lung cancer tissues compared with adjacent tissues; Inhibition of miR219a could promote the invasion and migration of lung cancer cells after silencing MEG3; The tumor volume and weight of MEG3-siRNA + miR-219a-inhibitor group were significantly increased compared with MEG3-siRNA group. The expression of Notch pathway protein was down-regulated after silencing MEG3. The number of microfilament microtubules decreased and the number of pseudopods decreased after silencing MEG3. Conclusion: MEG3 plays an important role in the development of lung cancer. MEG3 can regulate the invasion and migration ability of miR219a through Notch signaling pathway.

LncRNA MEG3 Repressed Malignant Melanoma Progression Via Inactivating Wnt Signaling Pathway

Upregulation LncRNA MEG3 expression suppresses proliferation and metastasis in melanoma via miR-208/SOX4

LncRNA MEG8 Plays an Oncogenic Role in Hepatocellular Carcinoma Progression Through Mir-367-3p/14-3-3ζ/tgfβr1 Axis.

MEG 3 regulates the invasion and migration of lung cancer via targeting miR-219 a and through MAPK pathway

Long noncoding RNA MEG3 suppresses liver cancer cells growth through inhibiting β-catenin by activating PKM2 and inactivating PTEN.

LncRNA Meg3 Suppresses Hepatocellular Carcinoma in Vitro and Vivo Studies

Lncrna MEG3 Had Anti-Cancer Effects to Suppress Pancreatic Cancer Activity.

Long Noncoding RNA MEG3 Negatively Regulates Proliferation and Angiogenesis in Vascular Endothelial Cells.

LncRNA MEG3 has anti-activity effects of cervical cancer.

The Biological Roles and Molecular Mechanisms of Long Non-Coding RNA MEG3 in the Hallmarks of Cancer

Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression

MEG3 Inhibits Cell Proliferation, Invasion and Epithelial-Mesenchymal Transition in Laryngeal Squamous Cell Carcinoma.

Long Non-Coding RNA Maternally Expressed Gene 3 Affects Cell Proliferation, Apoptosis and Migration by Targeting the Microrna-9-5p/midkine Axis and Activating the Phosphoinositide-Dependent Kinase/akt Pathway in Hepatocellular Carcinoma.

LncRNA MEG3 inhibits cell proliferation and induces apoptosis in laryngeal cancer via miR‐23a/APAF‐1 axis

Hypermethylated long noncoding RNA MEG3 promotes the progression of gastric cancer.

Silencing of Lncrna MEG8 Represses the Viability, Migration, and Invasion of Wilms’ Tumor Cells Through Mediating Mir-23A-3p/crk Axis

LncRNA MEG3 Inhibits the Epithelial-mesenchymal Transition of Bladder Cancer Cells through the Snail/E-cadherin Axis

Long Non-Coding Rna Meg3 Functions As A Tumour Suppressor And Has Prognostic Predictive Value In Human Pancreatic Cancer

Long non-coding RNA MEG3 functions as a competing endogenous RNA of miR-93 to regulate bladder cancer progression via PI3K/AKT/mTOR pathway

High expression of lncRNA MEG3 participates in non-small cell lung cancer by regulating microRNA-7-5p

Downregulation of MEG3 Promotes Neuroblastoma Development Through FOXO1-mediated Autophagy and Mtor-Mediated Epithelial-Mesenchymal Transition.